Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michelle Lynn Resler"'
Autor:
Tara K. Gregory, Jesus G. Berdeja, Robert Z. Orlowski, Matthew A. Spear, Eric M. Ostertag, Krina K. Patel, Adam D. Cohen, Devon J. Shedlock, Michelle Lynn Resler, Syed Abbas Ali, Caitlin Costello, Christopher E. Martin
Publikováno v:
Blood. 132:1012-1012
P-BCMA-101 is a novel chimeric antigen receptor (CAR)-T cell therapeutic targeting BCMA, which is highly expressed on MM cells. It is designed to increase efficacy while minimizing toxicity through reduced immunogenicity, lack of tonic signaling, a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a6a78f007086946895e455bbce81e7d
https://doi.org/10.1182/blood-2018-99-111419
https://doi.org/10.1182/blood-2018-99-111419
Autor:
Matthew A. Spear, Robert Z. Orlowski, Eric M. Ostertag, Adam D. Cohen, Jesus G. Berdeja, Tara K. Gregory, Syed Abbas Ali, Caitlin Costello, Michelle Lynn Resler, Devon J. Shedlock, Krina K. Patel, Nishan de Silva
Publikováno v:
Cancer Research. 78:CT130-CT130
Background: P-BCMA-101 is a novel chimeric antigen receptor (CAR)-T cell therapy designed to increase efficacy while minimizing toxicity through reduced immunogenicity, lack of tonic signaling, a safety switch, high purity (>95% CAR+) and a Tscm ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4f2ddf387202ed28d1a9107deef2620
https://doi.org/10.1158/1538-7445.am2018-ct130
https://doi.org/10.1158/1538-7445.am2018-ct130